•  
  •  
  •  
  •  

2023-01-30 17:25:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • SRF Ltd reports consolidated PAT of Rs. 510.90 crores in Q3FY23
  • RRIL Ltd consolidated Q3FY23 profit slips QoQ to Rs. 2.75 crore
  • Transport Corporation of India Ltd declares 2nd interim dividend of Rs. 2.50
  • QGO Finance Ltd declares 3rd interim dividend of 1%
  • SBI sanctions Rs. 450 crores credit facilities to Paisalo Digital Limited

Keywords Selected:  Pharmaceuticals

Research

  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

Stock Report

  • Fredun Pharmaceuticals Ltd Q3 FY2023 PAT increases to Rs. 3.45 crore
  • Glenmark Pharmaceuticals Ltd updates on Baddi facility
  • Pharmaids Pharmaceuticals Ltd signs investment agreement with Anugraha Chemicals
  • Torrent Pharmaceuticals Ltd declares interim dividend of Rs. 14
  • Torrent Pharmaceuticals Ltd Q3FY23 consolidated PAT slips QoQ to Rs. 283 crores
  • Shree Ganesh Remedies Ltd fixes Feb 3, 2023 as record date for rights issue
  • Earum Pharmaceuticals Ltd board approves rights issue
  • Granules Pharmaceuticals Inc., receives ANDA Approval for Amphetamine Mixed Salts ER Capsules
  • Glenmark launches AKYNZEO® I.V. in India
  • Shukra Pharmaceuticals Ltd fixes Feb 2, 2023 as record date for rights issue
  • Bafna Pharmaceuticals Ltd awarded with MSME-ZED certified GOLD CERTIFICATE
  • Strides Pharma Science Ltd successfully completes WHO PQ inspection at Puducherry Facility
  • IOL Chemicals and Pharmaceuticals Ltd receives EUGMP certification from Hungary authorities
  • Rajiv Gandhi appointed as Chairman FICCI Gujarat State Council
  • Laurus Labs Ltd receives EIR from USFDA for Unit 5, Parawada, Vizag
  • Dr. Reddy's successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
  • Sun Pharma to acquire Concert Pharmaceuticals, advancing the Potential Treatment of Alopecia Areata
  • Alembic Pharmaceuticals receives USFDA Tentative Approval for Acalabrutinib Capsules, 100 mg
  • Glenmark Pharmaceuticals Ltd to divest select brands to Eris Oaknet Healthcare Pvt Ltd
  • Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules
  • Piramal Pharma Ltd gets 2 observations from USFDA for Sellersville facility
  • Piramal Pharma Ltd gets 6 observations from USFDA for Lexington facility
  • Glenmark Pharmaceuticals launches Bumetanide Injection
  • Zydus launches Topiramate Extended-Release Capsules

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • SRF Ltd reports consolidated PAT of Rs. 510.90 crores in Q3FY23
  • RRIL Ltd consolidated Q3FY23 profit slips QoQ to Rs. 2.75 crore
  • Transport Corporation of India Ltd declares 2nd interim dividend of Rs. 2.50
  • QGO Finance Ltd declares 3rd interim dividend of 1%
  • SBI sanctions Rs. 450 crores credit facilities to Paisalo Digital Limited


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022